Maravai LifeSciences Holdings, Inc. provided earnings guidance for the fiscal year 2024. For the year, the company expects revenue to be in the range of $265.0 million to $285.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.34 USD | +0.18% | +7.69% | +73.13% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+73.13% | 1.51B | |
-31.06% | 9.41B | |
-8.43% | 3.03B | |
+27.31% | 2.9B | |
-14.31% | 2.16B | |
-18.94% | 1.7B | |
+30.25% | 814M | |
-1.97% | 760M | |
-26.73% | 529M | |
+5.17% | 312M |
- Stock Market
- Equities
- MRVI Stock
- News Maravai LifeSciences Holdings, Inc.
- Maravai LifeSciences Holdings, Inc. Provides Earnings Guidance for the Fiscal Year 2024